Practical information on using baloxavir

Baloxavir marboxil, a prodrug of baloxavir, is a selective inhibitor of influenza cap-dependent endonuclease that blocks replication of influenza virus A and BWHO 2024Uyeki 2018CDC 2022. It is recommended for treatment and prevention of influenza in select patient groups, administered as a single oral dose.